Economic TimesAstraZeneca PLC heart pill gets US approval while Pfizer bid battle turns politicalProactive Investors UKBid target AstraZeneca (LON:AZN) has received US approval for Epanova, its treatment for heart disease. The US Food and Drug Administration (FDA) has approved Epanova as an adjunct to diet to reduce fatty acid (triglyceride) levels in adults with severe …FDA approves AZ’s fish oil drugPMLiVEFDA Approves EPANOVA for the Treatment of Adults with Severe …Wall Street JournalAstraZeneca wins FDA approval of Epanova drugIFA MagazineThe Times (subscription) -Reuters UKall 17 news articles …Read Full Story
AstraZeneca PLC heart pill gets US approval while Pfizer bid battle turns political - Proactive Investors UK
Real Estate of Cebu
